A novel method utilizing markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes

Haematologica

Volumn 85, Issue 6, 2000, Pages 564-572

  Parisotto, Robin ^a   Gore, Christopher J ^a   Emslie, Kerry R ^b   Ashenden, Michael J ^a   Brugnara, Carlo ^c   Howe, Chris ^b   Martin, David T ^a   Trout, Graham J ^b   Hahn, Allan G ^a  

^a AUSTRALIAN INSTITUTE OF SPORT   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Athletes; Macrocytes; r HuEPO; Reticulocytes; Soluble transferrin receptor

Indexed keywords

ERYTHROPOIETIN; FERRITIN; FERROUS SULFATE; FERUM H; HEMOGLOBIN; IRON; OXYGEN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER; RECOMBINANT PROTEIN;

ADULT; ARTICLE; ATHLETE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MISUSE; DYSERYTHROPOIESIS; ENDURANCE; ERYTHROCYTE VOLUME; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HYPERTENSION; MALE; MATHEMATICAL MODEL; NORMAL HUMAN; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; TRAINING; ADDICTION; ANALYSIS OF VARIANCE; BLOOD; BLOOD GAS ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; CYTOLOGY; DOPING; ERYTHROCYTE; LABORATORY DIAGNOSIS; METABOLISM; METHODOLOGY; MULTICENTER STUDY; RETICULOCYTE;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; DIAGNOSIS, COMPUTER-ASSISTED; DOPING IN SPORTS; DOUBLE-BLIND METHOD; ERYTHROCYTES; ERYTHROPOIETIN; FALSE POSITIVE REACTIONS; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; MALE; RECEPTORS, TRANSFERRIN; RECOMBINANT PROTEINS; RETICULOCYTES; SUBSTANCE-RELATED DISORDERS;

EID: 0033624047     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sawka MN, Joyner MJ, Miles DS, Robertson RJ, Spriet LL, Young AJ. American College of Sports Medicine Position Stand. The use of blood doping as an ergogenic aid. Med Sci Sports Exerc 1996; 28:I-VIII.
2. Ekblom B, Berglund B. Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1991; 1:88-93.
3. Audran M, Gareau R, Matecki S, et al. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc 1999; 31:639-45.
4. Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991; 229:125-30.
5. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995; 47:740-5.
6. Maschio G. Erythropoietin and systemic hypertension. Nephrol Dial Transplant 1995; 10 (Suppl 2):74-9.
7. Raine AE. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy. Lancet 1988; 1:97-100.
8. Harrison MH. Effects of thermal stress and exercise on blood volume in humans. Physiol Rev 1985; 65: 149-209.
9. Gareau R, Gagnon MG, Thellend C, et al. Transferrin soluble receptor: a possible probe for detection of erythropoietin abuse by athletes. Horm Metab Res 1994; 26:311-2.
10. Breymann C, Bauer C, Major A, et al. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. Br J Haematol 1996; 92:295-301.
11. Casoni I, Ricci G, Ballarin, E et al. Hematological indices of erythropoietin administration in athletes, Int J Sports Med 1993; 14:307-11.
12. Conconi F, Casoni I, Manfredini F, et al. Detection of erythropoietin administration in sports. Proceedings of the Second International Symposium on Drugs in Sport. Towards the use of blood samples in doping control? Lillehammer, Norway, August 29-31 1993. Blood samples in doping control.
13. Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med 1994; 96:139-45.
14. Souillard A, Audran M, Bressolle F, Gareau R, Duvallet A, Chanal J-L. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control. Br J Clin Pharmacol 1996; 42:355-64.
15. Johnson DL, Farrell FX, Barbone FP, et al. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Biochemistry 1998; 37:3699-710.
16. Wrighton NC, Balasubramanian P, Barbone FP, et al. Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nat Biotechnol 1997;15: 1261-5.
17. Brugnara C, Colella GM, Cremins J, et al. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron deficient erythropoiesis. J Lab Clin Med 1994; 123:660-7.
18. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity. Am J Clin Pathol 1997; 108:133-42.
19. Major A, Bauer C, Breymann C, Huch A, Huch R. rh-erythropoietin stimulates immature reticulocyte release in man. Br J Haematol 1994; 87:605-8.
20. Major A, Mathez-Loic F, Rohling R, Gautschi K, Brugnara C. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin. Br J Haematol 1997; 98:292-4.
21. Bressolle F, Audran M, Gareau R, Baynes RD, Guidicelli C, Gomeni R. Population pharmacodynamics for monitoring epoetin in athletes. Clin Drug Invest 1997; 14:233-42.
22. Gore CJ, Hahn G, Burge CM, Telford RD. VO2max and haemoglobin mass of trained athletes during high intensity training. Int J Sports Med 1997; 18:477-82.
23. Burge CM, Skinner SL. Determination of hemoglobin mass and blood volume with CO: evaluation and application of a method. J Appl Physiol 1995; 79:623-31.
24. Aron A, Aron EN. Statistical power and effect size. Statistics for psychology. Englewood Cliffs, New Jersey: Prentice Hall; 1994, p. 206-47.
25. Gore CJ, Scroop GC, Marker JD, Catcheside PG. Plasma volume, osmolarity, total protein and electrolytes during treadmill running and cycle ergometer exercise. Eur J Appl Physiol 1992; 65:302-10.
26. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 1999; 69:S61-S66.
27. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998; 28:1-11.
28. Drueke TB, Barany P, Cazzola M, et al. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 1997; 48:1-8.
29. Tarng DC, Huang TP, Chen TW, Yang WC. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl 1999; 69:S107-S118.
30. Gunga HC, Kirsch K, Rocker L, Schobersberger W. Time course of erythropoietin, triiodothyronine, thyroxine, and thyroid-stimulating hormone at 2,315 m. J Appl Physiol 1994; 76:1068-72.
31. Chapman RF, Stray-Gundersen J, Levine BD. Individual variation in response to altitude training. J Appl Physiol 1998; 85:1448-56.
32. Piehl Aulin K, Svedenhag J, Wide L, Berglund B, Saltin B. Short-term intermittent normobaric hypoxia -haematological, physiological and mental effects. Scand J Med Sci Sports 1998; 8:132-7.
33. Rusko HK, Penttinen JTT, Koistinen PO, Vähäsöyrinki PI, Leppäluoto JO. A new solution to simulate altitude and stimulate erythropoiesis at sea level in athletes. In: Viitasalo J, Kujala U, eds. The way to win. Helsinki: International Congress on Applied Research in Sports; 1994. p. 287-9.
34. Jung RC, Dill DB, Horton R, Horvath SM. Effects of age on plasma aldosterone levels and hemoconcentration at altitude. J Appl Physiol 1971; 31:593-7.
35. Jelkmann W. Renal erythropoietin: properties and production. Rev Physiol Biochem Pharmacol 1986; 104:139-215.
36. Hoffbrand AV, Pettit JE. Essential haematology. Oxford: Blackwell Scientific; 1993.